MX2016006788A - Composiciones antibacterianas. - Google Patents

Composiciones antibacterianas.

Info

Publication number
MX2016006788A
MX2016006788A MX2016006788A MX2016006788A MX2016006788A MX 2016006788 A MX2016006788 A MX 2016006788A MX 2016006788 A MX2016006788 A MX 2016006788A MX 2016006788 A MX2016006788 A MX 2016006788A MX 2016006788 A MX2016006788 A MX 2016006788A
Authority
MX
Mexico
Prior art keywords
antibacterial compositions
pharmaceutically acceptable
acceptable derivative
ceftibuten
cefpodoxime
Prior art date
Application number
MX2016006788A
Other languages
English (en)
Spanish (es)
Inventor
Vithalbhai Patel Mahesh
Bhagwat Sachin
Original Assignee
Wockhardt Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wockhardt Ltd filed Critical Wockhardt Ltd
Publication of MX2016006788A publication Critical patent/MX2016006788A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/439—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom the ring forming part of a bridged ring system, e.g. quinuclidine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A61K31/542—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/545—Compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins, cefaclor, or cephalexine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A61K31/542—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/545—Compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins, cefaclor, or cephalexine
    • A61K31/546—Compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins, cefaclor, or cephalexine containing further heterocyclic rings, e.g. cephalothin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
MX2016006788A 2013-11-26 2014-11-26 Composiciones antibacterianas. MX2016006788A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IN3704MU2013 IN2013MU03704A (OSRAM) 2013-11-26 2014-11-26
PCT/IB2014/066351 WO2015079389A1 (en) 2013-11-26 2014-11-26 Antibacterial compositions

Publications (1)

Publication Number Publication Date
MX2016006788A true MX2016006788A (es) 2016-09-07

Family

ID=52347362

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2016006788A MX2016006788A (es) 2013-11-26 2014-11-26 Composiciones antibacterianas.

Country Status (10)

Country Link
US (2) US20160296502A1 (OSRAM)
EP (1) EP3074014A1 (OSRAM)
JP (1) JP6525999B2 (OSRAM)
KR (1) KR20160090311A (OSRAM)
CN (1) CN105792827B (OSRAM)
BR (1) BR112016012053A2 (OSRAM)
CA (1) CA2931070A1 (OSRAM)
IN (1) IN2013MU03704A (OSRAM)
MX (1) MX2016006788A (OSRAM)
WO (1) WO2015079389A1 (OSRAM)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX2018014813A (es) * 2016-06-17 2019-03-14 Wockhardt Ltd Composiciones antibacterianas.
KR20190039137A (ko) * 2016-07-14 2019-04-10 아카오젠, 인코포레이티드 박테리아 감염 치료에서 사용하기 위한 세프티부텐과 클라불란산의 조합
JP7012924B2 (ja) * 2017-03-02 2022-02-15 ウォックハート リミテッド 抗菌化合物としての複素環誘導体

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8796257B2 (en) * 2011-12-02 2014-08-05 Naeja Pharmaceutical Inc. Bicyclic compounds and their use as antibacterial agents and β-lactamase inhibitors
AR091222A1 (es) * 2012-05-30 2015-01-21 Meiji Seika Pharma Co Ltd INHIBIDOR DE b-LACTAMASA Y PROCESO PARA PREPARARLO
CA2881169C (en) * 2012-08-25 2020-06-16 Wockhardt Limited 1,6-diazabicyclo [3,2,1]octan - 7 - one derivatives and their use in the treatment of bacterial infections

Also Published As

Publication number Publication date
CN105792827B (zh) 2020-09-08
WO2015079389A1 (en) 2015-06-04
CA2931070A1 (en) 2015-06-04
JP2016537386A (ja) 2016-12-01
KR20160090311A (ko) 2016-07-29
CN105792827A (zh) 2016-07-20
EP3074014A1 (en) 2016-10-05
IN2013MU03704A (OSRAM) 2015-07-31
BR112016012053A2 (pt) 2017-08-08
US20180243274A1 (en) 2018-08-30
JP6525999B2 (ja) 2019-06-05
US20160296502A1 (en) 2016-10-13

Similar Documents

Publication Publication Date Title
EP3847168B8 (en) New anthelmintic compounds
MX2016011992A (es) Derivados de piperidina-diona.
NZ739676A (en) Heteroaryl compounds as irak inhibitors and uses thereof
PH12016501813B1 (en) 1,3-benzodioxole derivative
PH12018500591A1 (en) Heterocyclic compounds and uses thereof
GEP20186933B (en) Substituted dihydroisoquinoline compounds
TW201613911A (en) Heterocyclic compounds and uses thereof
EP4643945A8 (en) Neuroactive steroids and methods of use thereof
WO2014144545A3 (en) Substituted benzoxazoles and methods of use thereof
PH12018500061A1 (en) Oxysterols and methods of use thereof
MX2017014035A (es) Formas solidas novedosas.
HK1248069A1 (zh) 去乙酰氧基微管溶素h及其类似物
MX2016013431A (es) Composiciones farmaceuticas que comprenden agentes antibacterianos.
MY162886A (en) Novel tetrahydropyridopyrimidine compound or salt thereof
MX2015015562A (es) Dihidropiridinona como inhibidores de monoacilglicerol aciltransferasa 2.
MX2018001517A (es) Derivados sustituidos de guanidina.
MX363530B (es) Compuesto de benzoxaborol tricíclico, método de preparación y uso del mismo.
IN2013MU03704A (OSRAM)
MA39877A (fr) Formes solides d'un composé pharmaceutiquement actif
IN2014MU00859A (OSRAM)
MX2016005160A (es) Composiciones farmaceuticas que comprenden agentes antibacterianos.
MX2016013428A (es) Composiciones farmaceuticas que comprenden agentes antibacterianos.
MX2016005539A (es) Composiciones farmaceuticas que comprenden agentes antibacterianos.
IN2013MU03309A (OSRAM)
IN2013MU03421A (OSRAM)